SERUM PON1 AND HDL RELATED PAF-AH ENZYME ACTIVITIES IN CORONARY ARTERY DISEASE PATIENTS WITH HIGH CIRCULATING HDL LEVELS

被引：0
|
作者：
Kucuk, H. O. [1 ]
Kunak, T. [1 ]
Kucuk, U. [2 ]
Ulgen, A. [3 ]
Unlu, M. [2 ]
Abaci, A. [1 ]
机构：
[1] Gazi Univ Hosp, Dept Cardiol, Ankara, Turkey
[2] Gulhane Mil Med Acad, Dept Cardiol, Ankara, Turkey
[3] Hacettepe Univ Hosp, Dept Cardiol, Ankara, Turkey
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 163卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [1] Alterations of serum paraoxonase I (PON1) and serum and HDL-associated platelet-activating-factor acetylhydrolase (PAF-AH) activities during haemodialysis
    Liberopoulos, E
    Papavasiliou, E
    Tselepis, A
    Siamopoulos, K
    Elisaf, M
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 132 - 132
  • [2] Bioactive lipids improve serum HDL and PON1 activities in coronary artery disease patients: Ex-vivo study
    Khattib, Ali
    Shmet, Manar
    Levi, Achinoam
    Hayek, Tony
    Halabi, Majdi
    Khatib, Soliman
    VASCULAR PHARMACOLOGY, 2024, 157
  • [3] The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity
    Kakafika, AI
    Xenofontos, S
    Tsimihodimos, V
    Tambaki, AP
    Lourida, ES
    Kalaitzidis, R
    Cariolou, MA
    Elisaf, M
    Tselepis, AD
    JOURNAL OF LIPID RESEARCH, 2003, 44 (10) : 1919 - 1926
  • [4] Patients with coronary artery disease (CAD) homozygous for the B-Allele of high density lipoprotein (HDL) paraoxonase (PON1) exhibit reduced HDL-PON1 arylesterase activities of HDL subtractions HDL2 and HDL3
    Chemnitius, JM
    Winkel, H
    Armstrong, VW
    Zech, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 310A - 310A
  • [5] Patients with coronary artery disease homozygous for the B-allele of high-density lipoprotein (HDL) paraoxonase (PON1) exhibit reduced HDL-PON1 arylesterase activities of HDL subfractions HDL2 and HDL3
    Chemnitius, JM
    Winker, H
    Meyer, I
    Tebbe, U
    Zech, R
    EUROPEAN HEART JOURNAL, 2000, 21 : 276 - 276
  • [6] Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients
    Bounafaa, Abdelghani
    Berrougui, Hicham
    Ikhlef, Souade
    Essamadi, Abdelkhalid
    Nasser, Boubker
    Bennis, Ahmed
    Yamoul, Najoua
    Ghalim, Noreddine
    Khalil, Abdelouahed
    CLINICAL BIOCHEMISTRY, 2014, 47 (18) : 318 - 325
  • [7] Increase of HDL-associated platelet-activating-factor acetylhydrolase (PAF-AH) activity but not of paraoxonase (PON1) during haemodialysis
    Liberopoulos, E
    Papavasiliou, E
    Tzallas, C
    Katopodis, K
    Gouva, C
    Christidis, D
    Tselepis, A
    Siamopoulos, K
    Elisaf, M
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 336 - 336
  • [8] Serum PON1 activities are reduced with ageing: effects on the antioatherogenic properties of HDL
    Khalil, A
    Jaouad, L
    Milochevitch, C
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 297 - 297
  • [9] Comparison of serum acetyl hydrolase (PAF-AH) and paraoxonase 1 (PON1) values between prostate cancer patients and a control group
    Benli, Erdal
    Bayrak, Ahmet
    Cirakoglu, Abdullah
    Bayrak, Tulin
    Noyan, Tevfik
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2017, 33 (11): : 572 - 577
  • [10] The role of HDL-related myeloperoxidase (MPO) and paraoxonase 1 (PON1) in terms of coronary artery disease in Hashimoto’s thyroiditis
    Uncu G.
    Avcı E.
    Avci G.A.
    Karabulut A.
    Bilgi C.
    Comparative Clinical Pathology, 2023, 32 (2) : 273 - 279
12345